Categories Earnings, Technology

Accenture beats the market in Q3, raises guidance

Accenture (NYSE: ACN) reported a 4% increase in revenues in the third quarter of 2019 to $11.1 billion, surpassing the Wall Street projection of $11.04 billion.

Q3 earnings rose to $1.93 per share, from $1.60 per share in the year-over period, which included a $0.19 tax charge. The EPS was three cents higher than the street consensus of $1.89 per share.

accenture Q3 2019 earnings

New bookings for the quarter were $10.6 billion, with consulting bookings of $6.0 billion and outsourcing bookings of $4.6 billion.  

ACN shares were up slightly in green during pre-market hours on Thursday. Accenture shares have gained steadily since December last year when it dropped to a yearly low. The stock has grown about 13% in the past twelve months and hit a record high earlier this month.

Accenture CEO David Rowland said, “With revenue growth of 8.4 percent in local currency, we again gained significant market share. We also delivered strong profitability, generated outstanding free cash flow and returned $1.4 billion in cash to our shareholders.”

READ: Zscaler could be an ideal cybersecurity stock with long-term prospects

Outlook

Buoyed by the better-than-expected results, the company raised its outlook for the full fiscal year. For this period, the company now expects revenue growth in the range of 8-9% in local currency, compared with 6.5-8.5% previously. The company now expects diluted EPS to be in the range of $7.28 to $7.35, compared with $7.18 to $7.32 previously.

For the fourth quarter, Accenture expects revenues for the fourth quarter in the range of $10.85 billion to $11.15 billion, 5-8% growth in local currency.

Last month, Accenture’s main rival Cognizant Technology (CTSH) reported a 3% drop in first-quarter earnings to $0.91 per share on revenues of 44.1 billion, which is down 5% year-over-year. The results were hurt mainly by slower growth in financial and healthcare services.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

BIIB Earnings: Biogen Q1 2024 adj. earnings rise despite lower revenues

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to

Hasbro (HAS) Q1 2024 Earnings: Key financials and quarterly highlights

Hasbro, Inc. (NASDAQ: HAS) reported first quarter 2024 earnings results today. Revenues decreased 24% year-over-year to $757.3 million. Net earnings attributable to Hasbro, Inc. were $58.2 million, or $0.42 per

BA Earnings: Highlights of Boeing’s Q1 2024 financial results

The Boeing Company (NYSE: BA) on Wednesday announced financial results for the first quarter of 2024, reporting a narrower net loss, on an adjusted basis. Revenues dropped 8%. Core loss,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top